ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Cana Do Brejo

Also known as: Cana do Brejo, Monkey Cane, Cana-branca, Cana-do-mato, Caatinga, Pacová, Costus spicatus

Overview

Costus spicatus, commonly known as Cana do Brejo, is a herbaceous plant native to Brazil, particularly prevalent in moist forest regions like the Brazilian Cerrado. It belongs to the Costaceae family and has a long history of use in Brazilian folk medicine. Traditionally, it has been employed as a diuretic, anti-inflammatory, analgesic, and depurative agent, addressing conditions such as kidney problems, cystitis, edema, bruises, and certain infections. The plant contains a variety of bioactive compounds, including glycosylated flavonoids, organic acids, phenolics, saponins, and β-sitosterol. Current research, primarily at preclinical stages, suggests potential antioxidant, anti-inflammatory, hypoglycemic, and nephroprotective properties, though robust clinical evidence is still emerging.

Benefits

Costus spicatus exhibits several potential benefits, primarily supported by preclinical and ethnobotanical evidence. Its **antioxidant activity** has been observed in various models, demonstrating free radical scavenging capabilities and protective effects against oxidative stress, likely due to its flavonoid and phenolic content. **Anti-inflammatory effects** have been noted in animal studies and align with its traditional use for pain and inflammation relief, though specific mechanisms are not fully elucidated. Some research suggests **hypoglycemic effects**, indicating potential for blood glucose-lowering properties, which supports its traditional application in diabetes management. Furthermore, it shows **nephroprotective potential**, with ethnomedicinal use for renal colic and preclinical evidence hinting at kidney-protective effects. However, the strength of evidence for these benefits is limited by the lack of high-quality randomized controlled trials (RCTs), meaning clinical significance and effect sizes remain largely undetermined.

How it works

The mechanisms of action for Costus spicatus are thought to be multifaceted, primarily attributed to its rich phytochemical composition. Its **antioxidant effects** are likely mediated by compounds such as flavonoids and phenolic acids, which can neutralize reactive oxygen species, thereby reducing oxidative damage. The **anti-inflammatory actions** may involve the inhibition of pro-inflammatory mediators, though the precise molecular targets and pathways require further investigation. **Hypoglycemic effects** could stem from the modulation of glucose metabolism enzymes or improvements in insulin sensitivity, but detailed biochemical pathways are not yet fully characterized. The observed **diuretic and nephroprotective effects** may involve the plant's ability to modulate renal function and reduce oxidative stress within kidney tissues. Bioavailability data for its active compounds, such as glycosylated flavonoids, are scarce but suggest moderate absorption.

Side effects

Based on current research, Costus spicatus appears to have a favorable safety profile, with no significant toxicity reported in traditional use or preclinical studies. The reviewed literature does not document common or rare adverse effects. However, it is crucial to note that comprehensive clinical safety data are lacking. Information regarding specific drug interactions and contraindications is not well-studied, necessitating caution when used concurrently with other medications. Furthermore, the safety of Costus spicatus in special populations, such as pregnant or lactating individuals and children, has not been specifically investigated. Due to the limited clinical data, individuals should exercise prudence and consult a healthcare professional before using this supplement, especially if they have pre-existing health conditions or are taking other medications.

Dosage

Currently, there is no standardized or clinically established dosage for Costus spicatus. Traditional use typically involves preparing infusions or teas from the leaves and stems of the plant. Without clinical trials, specific dosage ranges for different purposes, timing considerations, or optimal forms for absorption remain undefined. There are no established upper limits or safety thresholds. For optimal phytochemical content, the plant is known to thrive in moist, organic-rich soils. Due to the lack of scientific consensus on dosing, individuals interested in using Costus spicatus should exercise caution and consult with a qualified healthcare practitioner to determine appropriate and safe usage, especially given the absence of data on absorption and cofactor requirements.

FAQs

Is Cana do Brejo safe to use?

Preclinical studies and traditional use suggest a low toxicity profile, but comprehensive clinical safety data are insufficient. Caution is advised due to limited research on adverse effects and drug interactions.

What conditions is Cana do Brejo traditionally used for?

It is traditionally used for kidney issues, inflammation, pain relief, and as a diuretic. Some traditional uses also include managing diabetes and certain infections, though scientific evidence is preliminary.

How should I take Cana do Brejo?

Traditionally, it is consumed as an herbal infusion or tea made from its leaves and stems. However, there is no standardized dosage or preparation method established by clinical research.

When can I expect to see results from Cana do Brejo?

There are no clinical trials available to define the onset of effects. Any observed benefits would be based on traditional use or anecdotal evidence, not scientifically established timelines.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC6732650/ – This review article by de Oliveira et al. (2019) explores medicinal plants from the Brazilian Cerrado, including Costus spicatus. It highlights preclinical findings suggesting antioxidant and anticancer activities with low toxicity, emphasizing the need for further clinical investigation.
  • http://www.rjlbpcs.com/article-pdf-downloads/2016/8/48.pdf – The literature review by Diré et al. (2016) synthesizes existing knowledge on Costus spicatus, pointing to its potential antioxidant, anti-inflammatory, and hypoglycemic properties. The authors call for more rigorous clinical studies to validate these ethnopharmacological and preclinical observations.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11901925/ – This review by de Oliveira et al. (2025) discusses nephroprotective plants used in Brazilian traditional medicine, featuring Costus spicatus for its potential renal benefits. It notes that while preclinical evidence exists, clinical efficacy for kidney protection remains unproven.

Supplements Containing Cana Do Brejo

F+ Female Plus by Systemic Formulas Bio Function
43

F+ Female Plus

Systemic Formulas Bio Function

Score: 43/100